Chesnara Plc: Fourth acquisition in two years
12 November 2026
Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, California, is gaining significant attention from investors with its potential for substantial upside...
Trevi Therapeutics, Inc. (NASDAQ: TRVI) emerges as a compelling player in the biotechnology sector with its focus on pioneering treatments for chronic cough and pruritus. The..
Investors eyeing the biotechnology sector may find Prothena Corporation plc (NASDAQ: PRTA) a compelling prospect, thanks to its significant upside potential and thriving pipeline in neurodegenerative..
For investors with a keen eye on biotechnology stocks, Verastem, Inc. (NASDAQ: VSTM) presents a particularly intriguing opportunity within the healthcare sector. With a market capitalization..
Rocket Pharmaceuticals, Inc. (RCKT) is a promising player in the biotechnology sector, focusing on the development of transformative gene therapies for rare and devastating diseases. With..
Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors eyeing growth in the..
AtaiBeckley Inc. (NASDAQ: ATAI), a rising star in the biotechnology sector, is capturing investor attention with its groundbreaking approach to mental health treatments. Specializing in the..
Personalis, Inc. (PSNL), a prominent player in the healthcare sector’s diagnostics and research industry, is gaining attention for its innovative cancer genomic tests and services. With..
Humacyte, Inc. (NASDAQ: HUMA), a burgeoning player in the biotechnology sector, has captured the attention of investors with its innovative approach to healthcare solutions. Specializing in..
Precigen, Inc. (NASDAQ: PGEN) has recently captured the attention of investors due to its significant growth potential within the biotechnology sector. The company, headquartered in Germantown,..
AbCellera Biologics Inc. (NASDAQ: ABCL), a prominent player in the biotechnology sector, is making waves with its robust pipeline of antibody-based medicines developed to address unmet..
Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company, has captured the attention of investors with its promising immunotherapy developments and impressive potential upside. With a market..
For investors hunting for opportunities in the healthcare sector, REGENXBIO Inc. (NASDAQ: RGNX) presents a compelling case with its strong potential upside. The biotechnology company, headquartered..
Bicycle Therapeutics plc (NASDAQ: BCYC), a clinical-stage pharmaceutical innovator, is capturing attention with its ambitious pipeline and robust analyst backing. With a potential upside of 239.35%,..
For investors venturing into the dynamic landscape of biotechnology, Tectonic Therapeutic, Inc. (NASDAQ: TECX) presents a compelling opportunity characterized by innovation and substantial growth potential. With..
Septerna, Inc. (NASDAQ: SEPN) is capturing the attention of investors in the healthcare sector with its significant growth potential and innovative contributions to biotechnology. As a..
EyePoint, Inc. (NASDAQ: EYPT) is capturing the attention of investors with its significant growth potential in the biotechnology sector. Specializing in the development and commercialization of..
Myriad Genetics, Inc. (NASDAQ: MYGN), a key player in the healthcare sector, continues to capture attention in the diagnostics and research industry. As the company navigates..
CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, is catching the attention of investors with its substantial revenue growth and an..
Sionna Therapeutics, Inc. (SION), a clinical-stage biopharmaceutical company, stands at the forefront of innovation in the biotechnology sector, focusing on groundbreaking treatments for cystic fibrosis (CF)...
